Literature DB >> 28936972

The summarized of EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.

Ramazan Idilman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28936972     DOI: 10.5152/tjg.2017.20817

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


× No keyword cloud information.
  5 in total

Review 1.  Nanomedicine based approaches for combating viral infections.

Authors:  Saurabh Shah; Mahavir Bhupal Chougule; Arun K Kotha; Rama Kashikar; Chandraiah Godugu; Rajeev Singh Raghuvanshi; Shashi Bala Singh; Saurabh Srivastava
Journal:  J Control Release       Date:  2021-08-08       Impact factor: 11.467

2.  Negative conversion of autoantibody profile in chronic hepatitis B: A case report.

Authors:  Xun Zhang; Qin-Xiu Xie; Dong-Mei Zhao
Journal:  World J Clin Cases       Date:  2021-02-16       Impact factor: 1.337

3.  Late Hepatitis B reactivation after treatment with rituximab.

Authors:  Sara Lacerda Pereira; Raquel Duro; António Sarmento
Journal:  IDCases       Date:  2022-01-10

4.  Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations.

Authors:  Jolynne Mokaya; Tetyana I Vasylyeva; Eleanor Barnes; M Azim Ansari; Oliver G Pybus; Philippa C Matthews
Journal:  J Viral Hepat       Date:  2021-05-07       Impact factor: 3.517

5.  The association of hepatitis B virus screening and antiviral prophylaxis with adverse liver outcomes in Chinese cancer patients undergoing chemotherapy: A retrospective study.

Authors:  Lan-Ying He; Yu-Lan Wang; Xu Tian; Wei-Qing Chen
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.